Inventor · disambiguated record
Meredith Hazen
Also filed as: HAZEN MEREDITH · HAZEN MEREDITH C · HAZEN MEREDITH CARROLL
14 granted patents·13 pending applications·57 citations·filing 2008–2025
90Inventor score
Top patents by PatentIndex Score
27 records- 0195US10017572B2Anti-tigit antibodies and methods of useGENENTECH INC·Filed 2016·Granted Jul 10, 2018·19 cites·22 claims
- 0294US10047158B2Anti-TIGIT antibodies and methods of useGENENTECH INC·Filed 2018·Granted Aug 14, 2018·13 cites·30 claims
- 0392US10723795B2Anti-interleukin-33 antibodies and uses thereofGENENTECH INC·Filed 2018·Granted Jul 28, 2020·6 cites·67 claims
- 0486US11226341B2Method of treating asthma using an IL-13 antibodyGENENTECH INC·Filed 2018·Granted Jan 18, 2022·4 cites·27 claims
- 0586US10093730B2Anti-interleukin-33 antibodies and uses thereofGENENTECH INC·Filed 2015·Granted Oct 9, 2018·6 cites·58 claims
- 0684US2024117037A1Anti-tigit antibodies and methods of useGENENTECH INC·Filed 2023·Application pending·0 cites
- 0784US2023279102A1Anti-tigit antibodies and methods of useGENENTECH INC·Filed 2022·Application pending·0 cites
- 0883US11725050B2Anti-interleukin-33 antibodies and uses thereofGENENTECH INC·Filed 2020·Granted Aug 15, 2023·1 cites·28 claims
- 0978US2025326837A1Anti-tigit antibodies and methods of useGENENTECH INC·Filed 2025·Application pending·0 cites
- 1077US10435471B2Anti-FcRH5 antibodiesGENENTECH INC·Filed 2014·Granted Oct 8, 2019·3 cites·49 claims
- 1177US2022064286A1Anti-tigit antibodies and methods of useGENENTECH INC·Filed 2021·Application pending·0 cites
- 1275US2021253693A1Anti-tigit antibodies and methods of useGENENTECH INC·Filed 2021·Application pending·0 cites
- 1374US2023096941A1Anti-fcrh5 antibodiesGENENTECH INC·Filed 2022·Application pending·0 cites
- 1473US9684000B2Diagnosis and treatments relating to TH2 inhibitionGENENTECH INC·Filed 2013·Granted Jun 20, 2017·2 cites·22 claims
- 1572US12486315B2Developing an efficient hybridoma platform for therapeutic antibody discoveryGENENTECH INC·Filed 2022·Granted Dec 2, 2025·0 cites·17 claims
- 1672US9995755B2Diagnosis and treatments relating to TH2 inhibitionGENENTECH INC·Filed 2013·Granted Jun 12, 2018·2 cites·17 claims
- 1772US2021032328A1Anti-tigit antibodies and methods of useGENENTECH INC·Filed 2020·Application pending·0 cites
- 1870US11352431B2Anti-FCRH5 antibodiesGENENTECH INC·Filed 2019·Granted Jun 7, 2022·0 cites·20 claims
- 1966US2019119376A1Anti-tigit antibodies and methods of useGENENTECH INC·Filed 2018·Application pending·0 cites
- 2065US8691222B2NLRR-1 antagonists and uses thereofHAZEN MEREDITH·Filed 2008·Granted Apr 8, 2014·1 cites·16 claims
- 2152US9580514B2Compositions and methods for the diagnosis and treatment of tumorGENENTECH INC·Filed 2013·Granted Feb 28, 2017·0 cites·16 claims
- 2249US2013058960A1Compositions and methods for the diagnosis and treatment of tumorGENENTECH INC·Filed 2012·Application pending·0 cites
- 2349US2012156194A1Diagnosis and treatments relating to th2 inhibitionARRON JOSEPH R·Filed 2011·Application pending·0 cites
- 2448US2014328849A1Anti-crth2 antibodies and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 2545US2017129963A1Compositions and methods for the diagnosis and treatment of tumorGENENTECH INC·Filed 2016·Application pending·0 cites
- 2639US10005848B2Method of reducing blood glucose by administering RON agonistsGENENTECH INC·Filed 2015·Granted Jun 26, 2018·0 cites·5 claims
- 2738US2016090422A1Anti-crth2 antibodies and methods of useGENENTECH INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Meredith Hazen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →